Canakinumab with Standard of Care for Patients with Advanced NSCLC: T-cell Infiltration Analysis in CANOPY-1

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorTAN, D. S.
dc.contributor.authorFELIP, E.
dc.contributor.authorCASTRO JUNIOR, G. de
dc.contributor.authorSOLOMON, B. J.
dc.contributor.authorGREYSTOKE, A.
dc.contributor.authorCHO, B. C.
dc.contributor.authorCOBO, M.
dc.contributor.authorKIM, T. M.
dc.contributor.authorGANGULY, S.
dc.contributor.authorWU, J.
dc.contributor.authorDEMANSE, D.
dc.contributor.authorBUTLER, A. A.
dc.contributor.authorBRASE, J. C.
dc.contributor.authorBOSSEN, C.
dc.contributor.authorJOHNSON, B. E.
dc.date.accessioned2024-03-08T15:15:04Z
dc.date.available2024-03-08T15:15:04Z
dc.date.issued2023
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.identifier.citationJOURNAL OF THORACIC ONCOLOGY, v.18, n.11, suppl.S, p.S313-S313, 2023
dc.identifier.eissn1556-1380
dc.identifier.issn1556-0864
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/58529
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INCeng
dc.relation.ispartofJournal of Thoracic Oncology
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright ELSEVIER SCIENCE INCeng
dc.subjectNSCLCeng
dc.subjectIL-1beng
dc.subjectbiomarkerseng
dc.subject.wosOncologyeng
dc.subject.wosRespiratory Systemeng
dc.titleCanakinumab with Standard of Care for Patients with Advanced NSCLC: T-cell Infiltration Analysis in CANOPY-1eng
dc.typeconferenceObjecteng
dc.type.categorymeeting abstracteng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryInglaterra
hcfmusp.affiliation.countryEspanha
hcfmusp.affiliation.countrySingapura
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countrySuíça
hcfmusp.affiliation.countryÍndia
hcfmusp.affiliation.countryCoréia do Sul
hcfmusp.affiliation.countryisosg
hcfmusp.affiliation.countryisoes
hcfmusp.affiliation.countryisogb
hcfmusp.affiliation.countryisokr
hcfmusp.affiliation.countryisoin
hcfmusp.affiliation.countryisous
hcfmusp.affiliation.countryisoch
hcfmusp.author.externalTAN, D. S.:Duke NUS Med Sch, Natl Canc Ctr Singapore, Singapore, Singapore
hcfmusp.author.externalFELIP, E.:Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain
hcfmusp.author.externalSOLOMON, B. J.:Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; Newcastle Univ & Newcastle Tyne Hosp NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England
hcfmusp.author.externalCHO, B. C.:Yonsei Univ, Yonsei Canc Ctr, Coll Med, Seoul, South Korea; IBIMA, Reg & Virgen Victoria Univ Hosp, Med Oncol Intercenter Unit, Malaga, Spain
hcfmusp.author.externalKIM, T. M.:Seoul Natl Univ Hosp, Seoul, South Korea
hcfmusp.author.externalGANGULY, S.:Tata Med Ctr, Kolkata, India
hcfmusp.author.externalWU, J.:Novartis Inst BioMed Res, Cambridge, MA USA
hcfmusp.author.externalDEMANSE, D.:Novartis Pharma AG, Basel, Switzerland
hcfmusp.author.externalBUTLER, A. A.:Novartis Pharmaceut, E Hanover, NJ USA
hcfmusp.author.externalBRASE, J. C.:Novartis Pharma AG, Basel, Switzerland
hcfmusp.author.externalJOHNSON, B. E.:Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
hcfmusp.contributor.author-fmusphcGILBERTO DE CASTRO JUNIOR
hcfmusp.description.beginpageS313
hcfmusp.description.endpageS313
hcfmusp.description.issue11
hcfmusp.description.issuesuppl S
hcfmusp.description.volume18
hcfmusp.origemWOS
hcfmusp.origem.wosWOS:001098831600521
hcfmusp.publisher.cityNEW YORKeng
hcfmusp.publisher.countryUSAeng
relation.isAuthorOfPublication0df25c0f-1337-424e-b0f7-41d0fccb51fc
relation.isAuthorOfPublication.latestForDiscovery0df25c0f-1337-424e-b0f7-41d0fccb51fc
Arquivos
Coleções
Comunicações em Eventos - HC/ICESP
Comunicações em Eventos - LIM/24